Medtronic reports third quarter fiscal 2022 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Medtronic, Inc. (MDT) PT Lowered to $124 at Needham & Company
February 22, 2022 1:59 PM ESTNeedham & Company analyst Michael Matson lowered the price target on Medtronic, Inc. (NYSE: MDT) to $124.00 (from $128.00) while maintaining a Buy rating following earnings.
The analyst commented, "MDT's F3Q22 revenue missed consensus while its EPS beat consensus and organic revenue growth slowed... More
Medtronic (MDT) Reports In-Line Q3 EPS; Guides Q4 In-Line
February 22, 2022 6:46 AM ESTMedtronic (NYSE: MDT) reported Q3 EPS of $1.37, in-line with the analyst estimate of $1.37. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $7.94 billion.
GUIDANCE:
Medtronic sees Q4 2022 EPS of $1.56-$1.58, versus the consensus of $1.58. The company... More
